560 related articles for article (PubMed ID: 11293642)
1. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
4. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
5. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure is insufficiently controlled in European patients with established coronary heart disease.
Boersma E; Keil U; De Bacquer D; De Backer G; Pyörälä K; Poldermans D; Leprotti C; Pilotto L; de Swart E; Deckers JW; Heidrich J; Sans S; Kotseva K; Wood D; Ambrosio GB;
J Hypertens; 2003 Oct; 21(10):1831-40. PubMed ID: 14508188
[TBL] [Abstract][Full Text] [Related]
7. Potential for cholesterol lowering in secondary prevention of coronary heart disease in europe: findings from EUROASPIRE study. European Action on Secondary Prevention through Intervention to Reduce Events.
Vanuzzo D; Pilotto L; Ambrosio GB; Pyörälä K; Lehto S; De Bacquer D; De Backer G; Wood D;
Atherosclerosis; 2000 Dec; 153(2):505-17. PubMed ID: 11164441
[TBL] [Abstract][Full Text] [Related]
8. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
9. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
10. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
11. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
13. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
Bowker TJ; Clayton TC; Ingham J; McLennan NR; Hobson HL; Pyke SD; Schofield B; Wood DA
Heart; 1996 Apr; 75(4):334-42. PubMed ID: 8705756
[TBL] [Abstract][Full Text] [Related]
14. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
15. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.
Pyörälä K; Lehto S; De Bacquer D; De Sutter J; Sans S; Keil U; Wood D; De Backer G;
Diabetologia; 2004 Jul; 47(7):1257-1265. PubMed ID: 15235774
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
[TBL] [Abstract][Full Text] [Related]
17. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
Mayer O; Simon J; Rosolová H; De Bacquer D;
Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
[TBL] [Abstract][Full Text] [Related]
18. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU
Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252
[TBL] [Abstract][Full Text] [Related]
19. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
[TBL] [Abstract][Full Text] [Related]
20. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.
Reiner Ž; De Bacquer D; Kotseva K; Prugger C; De Backer G; Wood D;
Atherosclerosis; 2013 Dec; 231(2):300-7. PubMed ID: 24267243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
